Skip to main content

Kidney, Adrenal Gland, and Retroperitoneum

  • Chapter
  • First Online:
Practical Cytopathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 1182 Accesses

Abstract

Fine needle aspiration (FNA) biopsy of kidney, adrenal, and retroperitoneal lesions yields challenging specimens in cytology due to the variety of diagnostic entities that can be encountered and their relative infrequency. Familiarity with the clinical and radiologic context is key to answer pertinent clinical questions at the time of rapid on-site evaluation (ROSE) and to render the complete final diagnosis for the case. This chapter is intended to provide a practical guide to cytopathologists evaluating these specimens in real time. It provides guidance on which entities to expect at the time of biopsy, how to allocate fresh specimen to maximize diagnostic yield, important information to convey at the time of ROSE, and key points that should be addressed in the final report, including classification and grading. An emphasis is placed on radiologic correlation, new entities and updates in recent WHO Classifications, ancillary testing, and potential pitfalls.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CT:

Computed tomography

EUS:

Endoscopic ultrasound

FISH:

Fluorescence in situ hybridization

FFPE:

Formalin-fixed paraffin-embedded

FNA:

Fine needle aspiration

GIST:

Gastrointestinal stromal tumor

HLRCC:

Hereditary leiomyomatosis and renal cell carcinoma syndrome

IHC:

Immunohistochemistry

MR:

Multiparametric magnetic resonance

N/C:

Nuclear to cytoplasmic ratio

ROSE:

Rapid on-site evaluation

WHO:

World Health Organization

References

  1. Diaz de Leon A, Pedrosa I. Imaging and screening of kidney cancer. Radiol Clin North Am [Internet]. Elsevier Inc. 2017;55(6):1235–50. Available from: https://doi.org/10.1016/j.rcl.2017.06.007.

    Article  Google Scholar 

  2. Low G, Huang G, Fu W, Moloo Z, Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol [Internet]. 2016;8(5):484. Available from: http://www.wjgnet.com/1949-8470/full/v8/i5/484.htm.

    Article  Google Scholar 

  3. Roh MH, Dal Cin P, Silverman SG, Cibas ES. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms. Cancer Cytopathol. 2010;118(3):137–45.

    Article  PubMed  Google Scholar 

  4. Cin PD, Qian X, Cibas ES. The marriage of cytology and cytogenetics. Cancer Cytopathol. 2013;121(6):279–90.

    Article  CAS  Google Scholar 

  5. Pisapia P, Lozano MD, Vigliar E, Bellevicine C, Pepe F, Malapelle U, et al. ALK and ROS1 testing on lung cancer cytologic samples: perspectives. Cancer Cytopathol. 2017;125(11):817–30.

    Article  CAS  PubMed  Google Scholar 

  6. Savic S, Bubendorf L. Common fluorescence in situ hybridization applications in cytology. Arch Pathol Lab Med. 2016;140(12):1323–30.

    Article  PubMed  Google Scholar 

  7. Micale M, Bernacki KD. Fluorescence in situ hybridization analysis on cytologic smears : an accurate and efficient method in the diagnosis of melanotic Xp11 translocation renal cancer. Diagn Cytopathol. 2018;46(9):786–9.

    Article  PubMed  Google Scholar 

  8. Renshaw AA, Cibas ES. Kidney and adrenal gland. In: Cibas ES, Ducatman BS, editors. Cytology: diagnostic principles and clinical correlates. 4th ed. Philadelphia (PA): Elsevier; 2014. p. 425.

    Google Scholar 

  9. Bindayi A, Hamilton ZA, Mcdonald ML, Yim K, Millard F, Mckay RR, et al. Neoadjuvant therapy for localized and locally advanced renal cell carcinoma. Urol Oncol Semin Orig Investig. 2018;36(1):31–7.

    Google Scholar 

  10. Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, et al. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol [Internet] Elsevier Ltd. 2014;192(2):357–63. Available from: https://doi.org/10.1016/j.juro.2014.03.006.

  11. Leppert JT, Hanley J, Wagner TH, Chung BI, Srinivas S, Chertow GM, Brooks JDSC. Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology. 2014;83(4):774–80.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, et al. Guideline for management of the clinical T1 renal mass. J Urol [Internet] Elsevier Inc. 2009;182(4 SUPPL):1271–9. Available from: https://doi.org/10.1016/j.juro.2009.07.004.

  13. Bishop JA, Hosler GA, Kulesza P, Erozan YS, Ali S. Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material? Diagn Cytopathol. 2011;39(3):168–71.

    PubMed  Google Scholar 

  14. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs—Part A: renal, penile, and testicular tumours. Eur Urol [Internet]. European Association of Urology. 2016;70(1):93–105. Available from: https://doi.org/10.1016/j.eururo.2016.02.029.

  15. Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10):1490–504.

    Article  PubMed  Google Scholar 

  16. Halverson SJ, Kunju LP, Bhalla R, Gadzinski AJ, Alderman M, Miller DC, et al. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol. 2013;189(2):441–6.

    Article  PubMed  Google Scholar 

  17. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol [Internet] European Association of Urology. 2016;69(4):660–73. Available from: https://doi.org/10.1016/j.eururo.2015.07.072.

  18. Choueiri TK, Cheville J, Palescandolo E, Fay AP, Kantoff PW, Atkins MB, et al. BRAF mutations in metanephric adenoma of the kidney. Eur Urol. 2012;62(5):917–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhou H, Zheng S, Truong LD, Ro JY, Ayala AG, Shen SS. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol [Internet] Elsevier Inc. 2014;45(1):59–64. Available from: https://doi.org/10.1016/j.humpath.2013.08.004.

  20. Merino MJ, Torres-Cabala C, Pinto P, Marston Linehan W. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31(10):1578–85.

    Article  PubMed  Google Scholar 

  21. Shyu I, Mirsadraei L, Wang X, Robila V, Mehra R, JB MH, Chen YB, Udager AM, Gill AJ, Cheng L, Amin MB, Lin O, Smith SC. Clues to recognition of fumarate hydratase deficient renal cell carcinoma: findings from cytologic and limited biopsy samples. Cancer Cytopathol [Internet]. 2018; Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncy.22071?af=R.

  22. Gill AJ, Hes O, Papathomas T, Šedivcová M, Tan PH, Agaimy A, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol [Internet]. 2014;38(12):1588–602. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4229399&tool=pmcentrez&rendertype=abstract.

    Article  Google Scholar 

  23. Paraf F, Vieillefond A, Paner JGP, Stovsky M, Young AN, Srigley JR, et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33(3):384–92.

    Article  PubMed  Google Scholar 

  24. Renshaw AA, Gould EW. Fine-needle aspiration of tubulocystic renal cell carcinoma. Diagn Cytopathol. 2018;46(8):707–10.

    Article  PubMed  Google Scholar 

  25. Sayeed S, Lindsey KG, Baras AS, Jackson C, Powers CN, Uram-Tuculescu C, et al. Cytopathologic features of clear cell papillary renal cell carcinoma: a recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms. Cancer Cytopathol. 2016;124(8):565–72.

    Article  PubMed  Google Scholar 

  26. Lin X. Cytomorphology of clear cell papillary renal cell carcinoma. Cancer Cytopathol. 2017;125(1):48–54.

    Article  CAS  PubMed  Google Scholar 

  27. Allen BC, Francis IR. Adrenal imaging and intervention. Radiol Clin North Am [Internet] Elsevier Inc. 2015;53(5):1021–35. Available from: https://doi.org/10.1016/j.rcl.2015.05.004.

  28. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol. 2008;190(5):1163–8.

    Article  Google Scholar 

  29. Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine [Internet] Springer US. 2017:1–9. Available from: https://doi.org/10.1007/s12020-017-1473-4.

  30. Paulsen SD, Nghiem HV, Korobkin M, Caoili EM, Higgins EJ. Changing role of imaging-guided percutaneous biopsy of adrenal masses: histopathology. AJR Am J Roentgenol. 2004;182(4):1033–7.

    Article  PubMed  Google Scholar 

  31. Villelli NW, Jayanti MK, Zynger DL. Use and usefulness of adrenal core biopsies without FNA or on-site evaluation of adequacy: a study of 204 cases for a 12-year period. Am J Clin Pathol. 2012;137(1):124–31.

    Article  PubMed  Google Scholar 

  32. Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341–4.

    Article  CAS  PubMed  Google Scholar 

  33. Delivanis DA, Erickson D, Atwell TD, Natt N, Maraka S, Schmit GD, et al. Procedural and clinical outcomes of percutaneous adrenal biopsy in a high-risk population for adrenal malignancy. Clin Endocrinol. 2016;85(5):710–6.

    Article  CAS  Google Scholar 

  34. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637–44.

    CAS  PubMed  Google Scholar 

  35. Lumachi F, Borsato S, Brandes AA, Boccagni P, Tregnaghi A, Angelini F, et al. Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors. Cancer. 2001;93(5):323–9.

    Article  CAS  PubMed  Google Scholar 

  36. Lam AK y. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017;28(3):213–27.

    Article  PubMed  Google Scholar 

  37. Crombag LMMJ, Szlubowski A, Stigt JA, Schuurbiers O, Korevaar DA, Bonta PI, et al. EUS-B-FNA vs conventional EUS-FNA for left adrenal gland analysis in lung cancer patients. Lung Cancer [Internet] Elsevier Ireland Ltd. 2017;108:38–44. Available from: https://doi.org/10.1016/j.lungcan.2017.02.011.

  38. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE. Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology [Internet]. 1993;187(3):715–8. Available from: papers2://publication/uuid/AF551055-2B91-4BA4-84C2-8BA93B78E9F6

    Article  CAS  Google Scholar 

  39. Eloubeidi MA, Black KR, Tamhane A, Eltoum IA, Bryant A, Cerfolio RJ. A large single-center experience of EUS-guided FNA of the left and right adrenal glands: diagnostic utility and impact on patient management. Gastrointest Endosc [Internet] Elsevier Inc. 2010;71(4):745–53. Available from: https://doi.org/10.1016/j.gie.2009.10.022.

  40. Fassina AS, Borsato S, Fedeli U. Fine needle aspiration cytology (FNAC) of adrenal masses. Cytopathology [Internet]. 2000;11(5):302–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11014657.

    Article  CAS  Google Scholar 

  41. Schuurbiers OCJ, Tournoy KG, Schoppers HJ, Dijkman BG, Timmers HJLM, de Geus-Oei LF, et al. EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer. Lung Cancer [Internet]. Elsevier Ireland Ltd. 2011;73(3):310–5. Available from: https://doi.org/10.1016/j.lungcan.2010.12.019.

  42. Bodtger U, Vilmann P, Clementsen P, Galvis E, Bach K, Skov BG. Clinical impact of endoscopic ultrasound-fine needle aspiration of left adrenal masses in established or suspected lung cancer. J Thorac Oncol [Internet] International Association for the Study of Lung Cancer. 2009;4(12):1485–9. Available from: https://doi.org/10.1097/JTO.0b013e3181b9e848.

  43. Suman P, Calcatera N, Wang CH, Moo-Young TA, Winchester DJ, Prinz RA. Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma. Am J Surg [Internet] Elsevier Inc. 2017;214(4):748–51. Available from: https://doi.org/10.1016/j.amjsurg.2017.01.039.

  44. Williams AR, Hammer GD, Else T. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome. Eur J Endocrinol. 2014;170(6):829–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sengupta S, Pal S, Biswas BK, Chakrabarti S, Bose K, Jana S. Fine-needle aspiration cytology of retroperitoneal lesions: a 5-year experience with an emphasis on cytohistological discrepancy. Acta Cytol. 2014;58(2):138–44.

    Article  PubMed  Google Scholar 

  46. Ansari H, Ahmad I, Mehdi G, Maheshwari V, Afzal S. Image-guided fine-needle aspiration of retroperitoneal masses: the role of the cytopathologist. J Cytol [Internet]. 2013;30(1):36. Available from: http://www.jcytol.org/text.asp?2013/30/1/36/107511.

    Article  Google Scholar 

  47. Gupta P, Rajwanshi A, Nijhawan R, Srinivasan R, Gupta N, Saikia UN, et al. Fine needle aspiration in retroperitoneal lesions. APMIS. 2017;125(1):16–23.

    Article  PubMed  Google Scholar 

  48. Tambo M, Fujimoto K, Miyake M, Hoshiyama F, Matsushita C, Hirao Y. Clinicopathological review of 46 primary retroperitoneal tumors. Int J Urol. 2007;14(9):785–8.

    Article  PubMed  Google Scholar 

  49. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS). A report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg. 2016;263(5):1002–9.

    Article  PubMed  Google Scholar 

  50. Akdamar M, Eltoum I, Eloubeidi M. Retroperitoneal paraganglioma: EUS appearance and risk associated with EUS-guided FNA. Gastrointest Endosc. 2004;60(6):1018–21.

    Article  PubMed  Google Scholar 

  51. Kubota K, Kato S, Mawatari H, Iida H, Akiyama T, Fujita K, et al. Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors. Dig Endosc. 2010;22:144–6.

    Google Scholar 

  52. Littrell LA, Carter JM, Broski SM, Wenger DE. Extra-adrenal myelolipoma and extramedullary hematopoiesis: imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma. Eur J Radiol [Internet] Elsevier. 2017;93(February):185–94. Available from: https://doi.org/10.1016/j.ejrad.2017.05.039.

  53. Policarpio‐Nicolas ML, Bregman SG, Ihsan M, Atkins KA. Mass-forming extramedullary hematopoiesis diagnosed by fine-needle aspiration cytology. Diagn Cytopathol. 2006;34(12):807–11.

    Article  PubMed  Google Scholar 

  54. Remstein ED, Kurtin PJ, Nascimento AG. Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders. Am J Surg Pathol. 2000;24(1):51–5.

    Article  CAS  PubMed  Google Scholar 

  55. Stein AL, Bardawil RG, Silverman S, Cibas E. Fine needle aspiration biopsy of idiopathic retroperitoneal fibrosis. Acta Cytol. 1997;41(2):461–6.

    Article  CAS  PubMed  Google Scholar 

  56. Forestier A, Buob D, Mirault T, Puech P, Gnemmi V, Launay D, Hachulla E, Hatron PY, Lambert M. No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases. Clin Exp Rheumatol. 2018;36(3):371–5.

    PubMed  Google Scholar 

  57. Kudo T, Kawakami H, Kuwatani M, Ehira N, Yamato H, Eto K, et al. Three cases of retroperitoneal schwannoma diagnosed by EUS-FNA. World J Gastroenterol. 2011;17(29):3459–64.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Pantanowitz L, Purgina B, Monaco S, Hs B, Jaffe R, Khalbuss W, et al. Cytomorphology of Erdheim-Chester disease presenting as a retroperitoneal soft tissue lesion. Cytojournal [Internet]. 2011;8(1):22. Available from: http://www.cytojournal.com/text.asp?2011/8/1/22/91242.

    Article  Google Scholar 

  59. Dong H, Dawes S, Philip J, Chaudhri S, Subramonian K. Malakoplakia of the urogenital tract. Urol Case Rep [Internet] Elsevier Inc. 2015;3(1):6–8. Available from: https://doi.org/10.1016/j.eucr.2014.10.002.

  60. Nieto-Ríos JF, Ramírez I, Zuluaga-Quintero M, Serna-Higuita LM, Gaviria-Gil F, Velez-Hoyos A. Malakoplakia after kidney transplantation: case report and literature review. Transpl Infect Dis. 2017;19(5):e12731.

    Article  Google Scholar 

  61. Yang YJ, Damron TA. Comparison of needle core biopsy and fine-needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med. 2004;128(7):759–64.

    PubMed  Google Scholar 

  62. Conner JR, Hirsch MS, Jo VY. HNF1β and S100α1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies [Internet]. Cancer Cytopathol. 2015;123(5):298–305. https://doi.org/10.1002/cncy.21530.

    Article  PubMed  Google Scholar 

  63. Magers MJ, Udager AM, Mehra R. MiT family translocation-associated renal cell carcinoma: a contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics. Arch Pathol Lab Med. 2015;139(10):1224–33.

    Article  CAS  PubMed  Google Scholar 

  64. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo CCD. Translocation renal cell carcinomas in adults: a single institution experience. Am J Surg Pathol. 2012;36(5):654–62.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Udager AM, Mehra R. Morphologic, molecular, and taxonomic evolution of renal cell carcinoma a conceptual perspective with emphasis on updates to the 2016 world health organization classification. Arch Pathol Lab Med. 2016;140(10):1026–37.

    Article  CAS  PubMed  Google Scholar 

  66. Sangoi AR, Fujiwara M, West RB, Montgomery KD, Bonventre JV, Higgins JP, et al. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases. Am J Surg Pathol [Internet]. 2011;35(5):678–86. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4124747&tool=pmcentrez&rendertype=abstract.

    Article  Google Scholar 

  67. Weissferdt A, Phan A, Suster S, Moran C. Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases. Appl Immunohistochem Mol Morphol. 2014;22(1):24–30.

    Article  CAS  PubMed  Google Scholar 

  68. Ye H, Ulbright TM. Difficult differential diagnoses in testicular pathology. Arch Pathol Lab Med. 2012;136(4):435–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alarice C. Lowe .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lowe, A.C. (2020). Kidney, Adrenal Gland, and Retroperitoneum. In: Xu, H., Qian, X., Wang, H. (eds) Practical Cytopathology . Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-24059-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24059-2_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24058-5

  • Online ISBN: 978-3-030-24059-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics